Journals / Eastern Journal of Medicine / 2011 / Cilt: 16 Sayı: 1

Biological monitoring of the ethylene oxide gas effects on medical utilities sterilization exposed staff

Pages
44–52
Publication Date
2013-01-21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There were genetically observed mutational changes located at p53 gene post EtO gas exposure.Key words: Ethylene oxide gas chronic exposure, T-lymphocytes subsets (CD3, CD4, CD8), p53 gene mutation

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic exposure to Ethylene Oxide (EtO) gas was suggested to be associated with many health hazards.
📊
Key Findings & Data:One group included 20 non exposed persons and served as a control group (group IV).
💡
Conclusion & Impact:There were genetically observed mutational changes located at p53 gene post EtO gas exposure.Key words: Ethylene oxide gas chronic exposure, T-lymphocytes subsets (CD3, CD4, CD8), p53 gene mutation
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ethylene oxide gas chronic exposure · T-lymphocytes subsets (CD3 · CD4

Abstract

Abstract. Chronic exposure to Ethylene Oxide (EtO) gas was suggested to be associated with many health hazards. This study was conducted on thirty one workers exposed to EtO gas in different production areas and classified into three groups; group I included seven workers with direct exposure, group II included thirteen workers with partial exposure and group III included eleven workers with indirect exposure. One group included 20 non exposed persons and served as a control group (group IV). All of them underwent analysis of complete blood count, T-lymphocytes subsets (CD3, CD4, CD8) by flowcytometery technique, serum IgG concentration by ELISA technique and p53 gene mutational changes. Platelet count was significantly reduced in all exposed groups. Both CD3% and CD4% were significantly decreased in group I and II (p≤0.05, p≤0.001) respectively. Also, the absolute value of T-helper lymphocytes was significantly reduced in group I and II (p≤0.05). However, CD8% was significantly increased only in group III (p≤0.05). A significant elevated value of total IgG was found in group I and II (p≤0.05). Variable gene mutation was detected in p53 exons (5b, 6 and 7) which were 28.5% (group I), 7.7% (group II) and 9% (group III) for exon 5b, 28.5% (group I) and 15.4% (group II) for exon 6 and 14.2% (group I), 7.7% (group II) and 9% (group III) for exon -7. There was significant reduced platelet count in all exposed groups. Both CD3% and CD4% and the absolute value of T-helper lymphocytes were significantly reduced in group I and II. EtO gas exposed personals showed a remarked IgG concentrations increments. There were genetically observed mutational changes located at p53 gene post EtO gas exposure.Key words: Ethylene oxide gas chronic exposure, T-lymphocytes subsets (CD3, CD4, CD8), p53 gene mutation

🔖

Cite This Article

KAMEL, M. M., HEWEHY, M. A. İ., HUSSEİN, A. H. M., SAMY, W. (2013). Biological monitoring of the ethylene oxide gas effects on medical utilities sterilization exposed staff. Eastern Journal of Medicine, Cilt: 16 Sayı: 1, 44–52. https://ajindex.com/articles/984974

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Lee C, John K, Mark F, Barbara C. Hemoglobin adducts and sister chromatid in hospital workers exposed to ethylene oxide: Effects of glutathione-s-transferase T1 and M1 genotypes. Cancer epidemiology biomarkers and prevention 2001; 10: 539- 550. Scholla AJ, Watkins WD, Guess WL. Comparative chemical and toxicological evaluation of residual ethylene oxide in sterilized plastics. J Pharm Sci 2006; 58: 1007-1010.
  2. Fennell TR, Brown CD. A physiologically based pharmacokinetic model for ethylene oxide in mouse, rat, and human. Toxicol Appl Pharmacol 2001; 173: 161-175.
  3. Thier R, Bolt HM. Carcinogenicity and genotoxicity of ethylene oxide: new aspects and recent advances. Crit Rev Toxicol 2000; 30: 595-608.
  4. Kolman A, Chovanec M, Osterman-Golkar S. Genotoxic effects of ethylene oxide, propylene oxide and epichlorohydrin in humans: update review (1990-2001). Mutat Res 2002; 512: 173-194.
  5. Romaguera C, Vilaplana J. Airborne occupational contact dermatitis from ethylene oxide. Contact Dermatitis J 1997; 11: 39-85.
  6. Ahlborg G Jr, Hemminki K. Reproductive effects of chemical exposures in health professions. J Occup Environ Med 1995; 37: 957-961.
  7. Nancy SV, Heuser SG. Ethylene oxide and its persistent reaction products in wheat flour and other Commodities: residues from fumigation or sterilization, and effects of processing. J Pestic Sci 2007; 2: 80-91.
  8. Wolfs P, Dutrieux M, Scailteur V, et al. Surveillance des travailleurs exposes à l'oxyde d'éthylène dans une entreprise de distribution de gaz stérilisants et dans des unités de stérilisation de matériel médical. Arch Mal Prof 1999; 44: 321-328.
  9. Yong LC, Schulte PA, Wiencke JK, et al. Hemoglobin adducts and sister chromatid exchanges in hospital workers exposed to ethylene oxide: effects of glutathione S- transferase T1 and M1 genotypes. Cancer Epidemiol Biomarkers Prev 2001; 10: 539- 550. Boogaard PJ. Use of haemoglobin adducts in exposure monitoring and risk assessment. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 778: 309-322.
  10. Burgaz S, Rezanko R, Kara S, Karakaya AE. Thioethers in urine of sterilization personnel exposed to ethylene oxide. J Clin Pharm Ther 1992; 17: 169-172.
  11. Potter R, Jorkasky JF. Engineering control of Ethylene Oxide exposures from gas sterilization in the safe use of Ethylene Oxide: proceedings of the educational seminar. Health Industry Manufacturers Association 2000; 80: 193-208. Anonymous. Guide to occupational exposure values. Cincinnati 2006; ACGIH: pp. 58-88.
  12. Vincent H, Brigitte M, Annette